For the detailed information of AS-2034178,AS 2034178, the solubility of AS-2034178,AS 2034178 in water, the solubility of AS-2034178,AS 2034178 in DMSO, the solubility of AS-2034178,AS 2034178 in PBS buffer, the animal experiment (test) of AS-2034178,AS 2034178, the cell expriment (test) of AS-2034178,AS 2034178, the in vivo, in vitro and clinical trial test of AS-2034178,AS 2034178, the EC50, IC50,and affinity,of AS-2034178,AS 2034178, For the detailed information of AS-2034178,AS 2034178, the solubility of AS-2034178,AS 2034178 in water, the solubility of AS-2034178,AS 2034178 in DMSO, the solubility of AS-2034178,AS 2034178 in PBS buffer, the animal experiment (test) of AS-2034178,AS 2034178, the cell expriment (test) of AS-2034178,AS 2034178, the in vivo, in vitro and clinical trial test of AS-2034178,AS 2034178, the EC50, IC50,and affinity,of AS-2034178,AS 2034178, Please contact DC Chemicals..

For the detailed information of BBS-4, the solubility of BBS-4 in water, the solubility of BBS-4 in DMSO, the solubility of BBS-4 in PBS buffer, the animal experiment (test) of BBS-4, the cell expriment (test) of BBS-4, the in vivo, in vitro and clinical trial test of BBS-4, the EC50, IC50,and affinity,of BBS-4, Please contact DC Chemicals..

For the detailed information of Betamethasone valerate (Betnovate), the solubility of Betamethasone valerate (Betnovate) in water, the solubility of Betamethasone valerate (Betnovate) in DMSO, the solubility of Betamethasone valerate (Betnovate) in PBS buffer, the animal experiment（test） (test) of Betamethasone valerate (Betnovate), the cell expriment (test) of Betamethasone valerate (Betnovate), the in vivo, in vitro and clinical trial test of Betamethasone valerate (Betnovate), the EC50, IC50,and Affinity of Betamethasone valerate (Betnovate),, please contact DC Chemicals..

For the detailed information of BIO-32546, the solubility of BIO-32546 in water, the solubility of BIO-32546 in DMSO, the solubility of BIO-32546 in PBS buffer, the animal experiment (test) of BIO-32546, the cell expriment (test) of BIO-32546, the in vivo, in vitro and clinical trial test of BIO-32546, the EC50, IC50,and affinity,of BIO-32546, For the detailed information of BIO-32546, the solubility of BIO-32546 in water, the solubility of BIO-32546 in DMSO, the solubility of BIO-32546 in PBS buffer, the animal experiment (test) of BIO-32546, the cell expriment (test) of BIO-32546, the in vivo, in vitro and clinical trial test of BIO-32546, the EC50, IC50,and affinity,of BIO-32546, Please contact DC Chemicals..

For the detailed information of Dimesna, the solubility of Dimesna in water, the solubility of Dimesna in DMSO, the solubility of Dimesna in PBS buffer, the animal experiment（test） (test) of Dimesna, the cell expriment (test) of Dimesna, the in vivo, in vitro and clinical trial test of Dimesna, the EC50, IC50,and Affinity of Dimesna,, please contact DC Chemicals..

For the detailed information of DTP3, the solubility of DTP3 in water, the solubility of DTP3 in DMSO, the solubility of DTP3 in PBS buffer, the animal experiment (test) of DTP3, the cell expriment (test) of DTP3, the in vivo, in vitro and clinical trial test of DTP3, the EC50, IC50,and affinity,of DTP3, Please contact DC Chemicals..

For the detailed information of Epothilone F, the solubility of Epothilone F in water, the solubility of Epothilone F in DMSO, the solubility of Epothilone F in PBS buffer, the animal experiment (test) of Epothilone F, the cell expriment (test) of Epothilone F, the in vivo, in vitro and clinical trial test of Epothilone F, the EC50, IC50,and Affinity of Epothilone F, Please contact DC Chemicals..

For the detailed information of GPI-1046, the solubility of GPI-1046 in water, the solubility of GPI-1046 in DMSO, the solubility of GPI-1046 in PBS buffer, the animal experiment (test) of GPI-1046, the cell expriment (test) of GPI-1046, the in vivo, in vitro and clinical trial test of GPI-1046, the EC50, IC50,and Affinity of GPI-1046, Please contact DC Chemicals..

For the detailed information of IN00076730, the solubility of IN00076730 in water, the solubility of IN00076730 in DMSO, the solubility of IN00076730 in PBS buffer, the animal experiment (test) of IN00076730, the cell expriment (test) of IN00076730, the in vivo, in vitro and clinical trial test of IN00076730, the EC50, IC50,and affinity,of IN00076730, For the detailed information of IN00076730, the solubility of IN00076730 in water, the solubility of IN00076730 in DMSO, the solubility of IN00076730 in PBS buffer, the animal experiment (test) of IN00076730, the cell expriment (test) of IN00076730, the in vivo, in vitro and clinical trial test of IN00076730, the EC50, IC50,and affinity,of IN00076730, Please contact DC Chemicals..

For the detailed information of JNJ40411813, the solubility of JNJ40411813 in water, the solubility of JNJ40411813 in DMSO, the solubility of JNJ40411813 in PBS buffer, the animal experiment (test) of JNJ40411813, the cell expriment (test) of JNJ40411813, the in vivo, in vitro and clinical trial test of JNJ40411813, the EC50, IC50,and Affinity of JNJ40411813, Please contact DC Chemicals..

For the detailed information of KF-4317, the solubility of KF-4317 in water, the solubility of KF-4317 in DMSO, the solubility of KF-4317 in PBS buffer, the animal experiment (test) of KF-4317, the cell expriment (test) of KF-4317, the in vivo, in vitro and clinical trial test of KF-4317, the EC50, IC50,and Affinity of KF-4317, Please contact DC Chemicals..

For the detailed information of LHW090-A7, the solubility of LHW090-A7 in water, the solubility of LHW090-A7 in DMSO, the solubility of LHW090-A7 in PBS buffer, the animal experiment (test) of LHW090-A7, the cell expriment (test) of LHW090-A7, the in viv

For the detailed information of Metroprolol succinate, the solubility of Metroprolol succinate in water, the solubility of Metroprolol succinate in DMSO, the solubility of Metroprolol succinate in PBS buffer, the animal experiment (test) of Metroprolol succinate, the cell expriment (test) of Metroprolol succinate, the in vivo, in vitro and clinical trial test of Metroprolol succinate, the EC50, IC50,and Affinity of Metroprolol succinate, Please contact DC Chemicals..

For the detailed information of Naxagolide, the solubility of Naxagolide in water, the solubility of Naxagolide in DMSO, the solubility of Naxagolide in PBS buffer, the animal experiment (test) of Naxagolide, the cell expriment (test) of Naxagolide, the in vivo, in vitro and clinical trial test of Naxagolide, the EC50, IC50,and Affinity of Naxagolide, Please contact DC Chemicals..

For the detailed information of NI-(S)-BPB-GLY, the solubility of NI-(S)-BPB-GLY in water, the solubility of NI-(S)-BPB-GLY in DMSO, the solubility of NI-(S)-BPB-GLY in PBS buffer, the animal experiment (test) of NI-(S)-BPB-GLY, the cell expriment (test) of NI-(S)-BPB-GLY, the in vivo, in vitro and clinical trial test of NI-(S)-BPB-GLY, the EC50, IC50,and Affinity of NI-(S)-BPB-GLY, Please contact DC Chemicals..

Nitenpyram is a chemical frequently used as an insecticide in agriculture and veterinary medicine. The compound is an insect neurotoxin belonging to the class of neonicotinoids which works by blocking neural signaling of the central nervous system.

For the detailed information of NSC157100, the solubility of NSC157100 in water, the solubility of NSC157100 in DMSO, the solubility of NSC157100 in PBS buffer, the animal experiment (test) of NSC157100, the cell expriment (test) of NSC157100, the in vivo, in vitro and clinical trial test of NSC157100, the EC50, IC50,and Affinity of NSC157100, Please contact DC Chemicals..

For the detailed information of NSC17711, the solubility of NSC17711 in water, the solubility of NSC17711 in DMSO, the solubility of NSC17711 in PBS buffer, the animal experiment (test) of NSC17711, the cell expriment (test) of NSC17711, the in vivo, in vitro and clinical trial test of NSC17711, the EC50, IC50,and Affinity of NSC17711, Please contact DC Chemicals..

For the detailed information of Ospemifene, the solubility of Ospemifene in water, the solubility of Ospemifene in DMSO, the solubility of Ospemifene in PBS buffer, the animal experiment (test) of Ospemifene, the cell expriment (test) of Ospemifene, the in vivo, in vitro and clinical trial test of Ospemifene, the EC50, IC50,and Affinity of Ospemifene, Please contact DC Chemicals..

For the detailed information of PB30239, the solubility of PB30239 in water, the solubility of PB30239 in DMSO, the solubility of PB30239 in PBS buffer, the animal experiment (test) of PB30239, the cell expriment (test) of PB30239, the in vivo, in vitro and clinical trial test of PB30239, the EC50, IC50,and Affinity of PB30239, Please contact DC Chemicals..

Pexmetinib is a potent Tie-2 and p38 MAPK dual inhibitor, with IC50s of 1 nM, 35 nM and 26 nM for Tie-2, p38α and p38β, respectively, and can be used in the research of acute myeloid leukemia.

For the detailed information of PF-0668759, the solubility of PF-0668759 in water, the solubility of PF-0668759 in DMSO, the solubility of PF-0668759 in PBS buffer, the animal experiment (test) of PF-0668759, the cell expriment (test) of PF-0668759, the

For the detailed information of Phenothrin, the solubility of Phenothrin in water, the solubility of Phenothrin in DMSO, the solubility of Phenothrin in PBS buffer, the animal experiment (test) of Phenothrin, the cell expriment (test) of Phenothrin, the in vivo, in vitro and clinical trial test of Phenothrin, the EC50, IC50,and affinity,of Phenothrin, For the detailed information of Phenothrin, the solubility of Phenothrin in water, the solubility of Phenothrin in DMSO, the solubility of Phenothrin in PBS buffer, the animal experiment (test) of Phenothrin, the cell expriment (test) of Phenothrin, the in vivo, in vitro and clinical trial test of Phenothrin, the EC50, IC50,and affinity,of Phenothrin, Please contact DC Chemicals..

For the detailed information of praeruptorin B, the solubility of praeruptorin B in water, the solubility of praeruptorin B in DMSO, the solubility of praeruptorin B in PBS buffer, the animal experiment（test） (test) of praeruptorin B, the cell expriment (test) of praeruptorin B, the in vivo, in vitro and clinical trial test of praeruptorin B, the EC50, IC50,and Affinity of praeruptorin B,, please contact DC Chemicals..

For the detailed information of PST2286, the solubility of PST2286 in water, the solubility of PST2286 in DMSO, the solubility of PST2286 in PBS buffer, the animal experiment (test) of PST2286, the cell expriment (test) of PST2286, the in vivo, in vitro and clinical trial test of PST2286, the EC50, IC50,and affinity,of PST2286, Please contact DC Chemicals..

For the detailed information of Reboxetine mesylate, the solubility of Reboxetine mesylate in water, the solubility of Reboxetine mesylate in DMSO, the solubility of Reboxetine mesylate in PBS buffer, the animal experiment（test） (test) of Reboxetine mesylate, the cell expriment (test) of Reboxetine mesylate, the in vivo, in vitro and clinical trial test of Reboxetine mesylate, the EC50, IC50,and Affinity of Reboxetine mesylate,, please contact DC Chemicals..

For the detailed information of RO 15-3890, the solubility of RO 15-3890 in water, the solubility of RO 15-3890 in DMSO, the solubility of RO 15-3890 in PBS buffer, the animal experiment (test) of RO 15-3890, the cell expriment (test) of RO 15-3890, the in vivo, in vitro and clinical trial test of RO 15-3890, the EC50, IC50,and Affinity of RO 15-3890, Please contact DC Chemicals..

A small molecule tumor translocation inhibitor that inhibits the prostate cancer cell transcriptional program, in part by inhibition of the demethylase KDM4C (IC50=30 uM).

For the detailed information of SKP2-C25, the solubility of SKP2-C25 in water, the solubility of SKP2-C25 in DMSO, the solubility of SKP2-C25 in PBS buffer, the animal experiment (test) of SKP2-C25, the cell expriment (test) of SKP2-C25, the in vivo, in vitro and clinical trial test of SKP2-C25, the EC50, IC50,and affinity,of SKP2-C25, For the detailed information of SKP2-C25, the solubility of SKP2-C25 in water, the solubility of SKP2-C25 in DMSO, the solubility of SKP2-C25 in PBS buffer, the animal experiment (test) of SKP2-C25, the cell expriment (test) of SKP2-C25, the in vivo, in vitro and clinical trial test of SKP2-C25, the EC50, IC50,and affinity,of SKP2-C25, Please contact DC Chemicals..

HIV-1 integrase inhibitor 8 is a HIV-1 integrase inhibitor, compound 8[1].

For the detailed information of SR03168, the solubility of SR03168 in water, the solubility of SR03168 in DMSO, the solubility of SR03168 in PBS buffer, the animal experiment (test) of SR03168, the cell expriment (test) of SR03168, the in vivo, in vitro and clinical trial test of SR03168, the EC50, IC50,and Affinity of SR03168, Please contact DC Chemicals..

For the detailed information of SR03298A, the solubility of SR03298A in water, the solubility of SR03298A in DMSO, the solubility of SR03298A in PBS buffer, the animal experiment (test) of SR03298A, the cell expriment (test) of SR03298A, the in vivo, in vitro and clinical trial test of SR03298A, the EC50, IC50,and Affinity of SR03298A, Please contact DC Chemicals..

For the detailed information of SR10067, the solubility of SR10067 in water, the solubility of SR10067 in DMSO, the solubility of SR10067 in PBS buffer, the animal experiment (test) of SR10067, the cell expriment (test) of SR10067, the in vivo, in vitro and clinical trial test of SR10067, the EC50, IC50,and affinity,of SR10067, For the detailed information of SR10067, the solubility of SR10067 in water, the solubility of SR10067 in DMSO, the solubility of SR10067 in PBS buffer, the animal experiment (test) of SR10067, the cell expriment (test) of SR10067, the in vivo, in vitro and clinical trial test of SR10067, the EC50, IC50,and affinity,of SR10067, Please contact DC Chemicals..

For the detailed information of Sulfamethazine, the solubility of Sulfamethazine in water, the solubility of Sulfamethazine in DMSO, the solubility of Sulfamethazine in PBS buffer, the animal experiment（test） (test) of Sulfamethazine, the cell expriment (test) of Sulfamethazine, the in vivo, in vitro and clinical trial test of Sulfamethazine, the EC50, IC50,and Affinity of Sulfamethazine,, please contact DC Chemicals..

For the detailed information of Tenovin-2, the solubility of Tenovin-2 in water, the solubility of Tenovin-2 in DMSO, the solubility of Tenovin-2 in PBS buffer, the animal experiment (test) of Tenovin-2, the cell expriment (test) of Tenovin-2, the in vivo, in vitro and clinical trial test of Tenovin-2, the EC50, IC50,and affinity,of Tenovin-2, Please contact DC Chemicals..

For the detailed information of Tenovin-5, the solubility of Tenovin-5 in water, the solubility of Tenovin-5 in DMSO, the solubility of Tenovin-5 in PBS buffer, the animal experiment (test) of Tenovin-5, the cell expriment (test) of Tenovin-5, the in vivo, in vitro and clinical trial test of Tenovin-5, the EC50, IC50,and affinity,of Tenovin-5, Please contact DC Chemicals..

For the detailed information of Tradipitant(VLY-686), the solubility of Tradipitant(VLY-686) in water, the solubility of Tradipitant(VLY-686) in DMSO, the solubility of Tradipitant(VLY-686) in PBS buffer, the animal experiment (test) of Tradipitant(VLY-686), the cell expriment (test) of Tradipitant(VLY-686), the in vivo, in vitro and clinical trial test of Tradipitant(VLY-686), the EC50, IC50,and affinity,of Tradipitant(VLY-686), For the detailed information of Tradipitant(VLY-686), the solubility of Tradipitant(VLY-686) in water, the solubility of Tradipitant(VLY-686) in DMSO, the solubility of Tradipitant(VLY-686) in PBS buffer, the animal experiment (test) of Tradipitant(VLY-686), the cell expriment (test) of Tradipitant(VLY-686), the in vivo, in vitro and clinical trial test of Tradipitant(VLY-686), the EC50, IC50,and affinity,of Tradipitant(VLY-686), Please contact DC Chemicals..

For the detailed information of Vonoprazan, the solubility of Vonoprazan in water, the solubility of Vonoprazan in DMSO, the solubility of Vonoprazan in PBS buffer, the animal experiment (test) of Vonoprazan, the cell expriment (test) of Vonoprazan, the in vivo, in vitro and clinical trial test of Vonoprazan, the EC50, IC50,and affinity,of Vonoprazan, For the detailed information of Vonoprazan, the solubility of Vonoprazan in water, the solubility of Vonoprazan in DMSO, the solubility of Vonoprazan in PBS buffer, the animal experiment (test) of Vonoprazan, the cell expriment (test) of Vonoprazan, the in vivo, in vitro and clinical trial test of Vonoprazan, the EC50, IC50,and affinity,of Vonoprazan, Please contact DC Chemicals..

For the detailed information of VRT-1353385, the solubility of VRT-1353385 in water, the solubility of VRT-1353385 in DMSO, the solubility of VRT-1353385 in PBS buffer, the animal experiment (test) of VRT-1353385, the cell expriment (test) of VRT-1353385, the in vivo, in vitro and clinical trial test of VRT-1353385, the EC50, IC50,and affinity,of VRT-1353385, For the detailed information of VRT-1353385, the solubility of VRT-1353385 in water, the solubility of VRT-1353385 in DMSO, the solubility of VRT-1353385 in PBS buffer, the animal experiment (test) of VRT-1353385, the cell expriment (test) of VRT-1353385, the in vivo, in vitro and clinical trial test of VRT-1353385, the EC50, IC50,and affinity,of VRT-1353385, Please contact DC Chemicals..

For the detailed information of Zucapsaicin, the solubility of Zucapsaicin in water, the solubility of Zucapsaicin in DMSO, the solubility of Zucapsaicin in PBS buffer, the animal experiment (test) of Zucapsaicin, the cell expriment (test) of Zucapsaicin, the in vivo, in vitro and clinical trial test of Zucapsaicin, the EC50, IC50,and affinity,of Zucapsaicin, For the detailed information of Zucapsaicin, the solubility of Zucapsaicin in water, the solubility of Zucapsaicin in DMSO, the solubility of Zucapsaicin in PBS buffer, the animal experiment (test) of Zucapsaicin, the cell expriment (test) of Zucapsaicin, the in vivo, in vitro and clinical trial test of Zucapsaicin, the EC50, IC50,and affinity,of Zucapsaicin, Please contact DC Chemicals..

Foretinib (GSK1363089; XL880; EXEL-2880; GSK089) is an ATP-competitive inhibitor of HGFR and VEGFR, mostly for Met and KDR with IC50 of 0.4 nM and 0.9 nM. Less potent against Ron, Flt-1/3/4, Kit, PDGFRα/β and Tie-2, and little activity to FGFR1 and EGFR.

Formestane(CGP-32349; 4-OHA) is a selective, type I, steroidal aromatase inhibitor used in the treatment of estrogen-receptor positive breast cancer.

Formoterol fumarate(Foradil) is a potent, selective and long-acting β2-adrenoceptor agonist.

Forskolin is a ubiquitous activator of eukaryotic adenylyl cyclase (AC).

Forsythoside B is a phenylethanoid glycoside isolated from the leaves of Lamiophlomis rotata Kudo, a Chinese folk medicinal plant for treating inflammatory diseases and promoting blood circulation.

Fosaprepitant (MK-0517, L-758,298) is a water-soluble phosphoryl prodrug for Aprepitant which is a NK1 antagonist.

Fosaprepitant (MK-0517, L-758,298) is a water-soluble phosphoryl prodrug for Aprepitant which is a NK1 antagonist.

Fosbretabulin disodium(CA 4DP; CA 4P) is a microtubule destabilizing drug, a type of vascular-targeting agent, a drug designed to damage the vasculature (blood vessels) of cancer tumors causing central necrosis.

Fosdagrocorat (PF 04171327) is an orally available, potential dissociated agonist of the glucocorticoid receptor (GR) for the treatment of rheumatoid arthritis, the phosphate ester prodrug of PF-00251802 (dagrocorat)..

Fosfluconazole (INN) is a water-soluble phosphate prodrug of fluconazole

Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation.

Fosmidomycin sodium salt is a phosphonic acid antibiotic and a antimalarial drug, which is active against both Gram-negative and Gram-positive bacteria.

Fosravuconazole is a prodrug of ravuconazole, with antifungal activity.

Fostamatinib (R788) is a prodrug of the active metabolite R406, which is a potent, ATP-competitive inhibitor of Syk kinase with Ki/IC50 of 30/41 nM.

Fosteabine is an oral and prodrug analogue of cytarabine which is resistant to deoxycytidine deaminase.

Foxy-5 is a novel Wnt-5A mimicking hexapeptide that inhibits breast cancer metastasis in vivo by targeting cell motility.

FPH1 (BRD-6125) is a small molecule, which promotes expansion of iPS-derived hepatocytes.

FPL64176 is a potent L-type Ca++ channel activator with EC50 of 16 nM.

FPS-ZM1 is a blood-brain-barrier permeant blocker of RAGE V domain-mediated ligand binding (Ki = 25, 148, & 230 nM, respectively.

FQI1 is a small-molecule inhibitor of transcription factor LSF with IC50 of 2.1 uM.

FQI2 is a small-molecule inhibitor of transcription factor LSF with IC50 of 0.71 uM.

FR 900098 is a derivative of fosmidomycin that inhibits DOXP reductoisomerase, demonstrates antimalarial activity with IC50 of 170, 170, and 90 nM for HB3, A2, and Dd2 P. falciparum strains, respectively..

FR194738 is a squalene epoxidase inhibitor. FR194738 inhibits squalene epoxidase activity in HepG2 cell homogenates with an IC50 of 9.8 nM.

FR58P1a is a mitochondrial metabolism-affecting compound that uncouples OXPHOS through a protonophoric mechanism, selectively inhibits migration in triple-negative breast cancer cells via Sirt1/AMPK/β1-integrin pathway.

FR-901464 is a potent antitumor natural product that binds to the splicing factor 3b (SF3b) complex and inhibits pre-mRNA splicing, inhibits cell cycle progression at G1 and G2/M phases..

Framycetin (Fradiomycin B; Neomycin B) is an aminoglycoside antibiotic. It inhibits hammerhead ribozyme with a Ki of 13.5 μM.

Framycetin sulphate

FRAX1036 is a novel ATP-competitive small molecule inhibitor of group I p21-activated Kinases (PAKs).

FRAX486 is a selective inhibitor of group I PAKs with IC50s of 8.25/39.5, /55.3 nM for PAK1/PAK2/PAK3 respectivelt; less potent for PAK4(IC50=779 nM).

FRAX597 is a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.

Fraxin is a coumarin glycoside that has been found in Fraxinus and has anti-inflammatory activity.

Fraxinellone is a selective blocker of voltage-dependent Ca2+ channel, which possesses antimicrobial, anti-inflammatory, neuroprotective and vasorelaxing activities.

Frentizole, an FDA-approved immunosuppressive drug, is a novel inhibitor of the Aβ-ABAD interaction.

Frovatriptan Succinate is the succinate salt form of frovatriptan, a synthetic triptan with serotonin (5-HT) receptor agonist activity especially for the 5-HT1B/1D receptors.

Fruquintinib (HMPL-013) is a novel small molecule compound that selectively inhibits vascular endothelial growth factor receptors (VEGFRs).

FSC 231 (FSC231) is the first, cell-permeable small-molecule inhibitor of PICK1 PDZ domain with Kd of 10.1 uM.

FT-001 is a novel potent, orally acitve inhibitor of BET bromodomain with IC50 of 0.1 uM for BRD4 BD1.

FT113 is a potent and orally active fatty acid synthase (FASN) inhibitor, with an IC50 of 213 nM for full-length recombinant human FASN enzyme.

FT-671 is a novel potent, specific, non-covalent USP7 inhibitor with Kd of 65 nM (USP7 catalytic domain).

FT895 (FT-895) is a potent and selective inhibitor of HDAC11 with IC50 of 3 nM, displays no significant activity against HDAC1-10 (IC50>5 uM).

FTBMT is a novel selective GPR52 agonist of GPR52, increases intracellular cAMP levels in CHO cells expressing human, mouse, or rat GPR52, with pEC50 of 7.03, 6.85, and 6.87M, respectively.

FTI 277 HCl is the methyl ester of FTI 277, which is a potent and selective farnesyltransferase (FTase) inhibitor with IC50 of 500 pM, about 100-fold selectivity over the closely related GGTase I.

FtsZ inhibitor C109 (Compound 10126109) is a broad spectrum antibacterial compound that inhibits the cell division protein FtsZ, inhibits the FtsZ GTPase activity with IC50 of 8.2 uM.

FTY720 (Fingolimod, Gilenya) is a S1P antagonist with IC50 of 0.033 nM.

Fuchsine base (monohydrochloride) is a magenta dye, which is certified for use for acid-fast staining with carbol-fuchsin.

Fudosteine

Fulacimstat(BAY 1142524) is a small molecule chymase inhibitor.

Fulvestrant is an estrogen receptor (ER) antagonist with IC50 of 0.094 nM.

Fumagillin is a selective and potent irreversible inhibitor of Methionine aminopeptidase 2 (MetAP2), used as an antibiotic to treat microsporidiosis.

Fumalic acid (Ferulic acid)

Fumosorinone is a novel potent, selective protein tyrosine phosphatase SHP2 inhibitor with IC50 of 6.31 uM.

Furamidine dihydrochloride (NSC 305831) tyrosyl-DNA phosphodiesterase (Tdp1), also is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with IC50 of 9.4 uM.

Furosemide (Lasix) is a loop diuretic inhibitor of Na+/2Cl-/K+ (NKCC) cotransporter of which used in the treatment of congestive heart failure and edema.

Fusidate Sodium is a sodium salt form of fusidic acid, a bacteriostatic antibiotic derived from the fungus Fusidium coccineum and used as a topical medication to treat skin infections.

FV-100 (Valnivudine, CF-1743) is a potent, selective, bicyclic nucleoside analogue inhibitor of varicella zoster virus (VZV) with EC50 of subnanomolar range in vitro..

FX1 is a novel specific inhibitor of the B cell lymphoma 6 (BCL6).

FzM1.8 is a small molecule, allosteric agonist of the Frizzled receptor Fzd4 with pEC50 of 6.4, potentiates β-catenin pathway in the absence of any WNT ligand.

G 0507 is a novel inhibitor of the bacterial LolCDE ABC transporter, binds to LolCDE and stimulates its ATPase activity.

G 573 is a potent and selective, allosteric inhibitor of MEK with Ki of 0.3 nM.

G007-LK is a potent, "rule of 5" compliant and a metabolically stable TNKS1/2 inhibitor.

G0775 is a Synethetic analogs of arylomycins.

G10 (STING Agonist 1) is a novel human-specific STING agonist.

G-15 is a cell-permeable non-steroidal antagonist of GPER (Ki = 20 nM).

G1T28(Trilaciclib) is a potential first-in-class, short-acting IV CDK4/6 inhibitor being developed to preserve hematopoietic stem cells and enhance immune system function during chemotherapy.

G-36 is a cell-permeable non-steroidal antagonist of GPER, inhibiting activation by either 17β-estradiol or the GPER-selective agonist G-1(IC50 = 112 and 165 nM, respectively).

G3-C12 (TFA) is a galectin-3 binding peptide, with high affinity (Kd) of 88 nM, but shows no affinity for other galectin family members or to other lectins.

G-5555 is a potent and selective PAK1 inhibitor (Ki=3.7 nM).

G6PD activator AG1 (AG1) is a specific, small molecule that increases the activity of the wild-type, Canton mutant (R459L, EC50=3 uM) and several other common G6PD mutants; displays no effect on the dimerization or activity of several other NAD- or NADP+-dependent dimeric or tetrameric enzymes, including 6PGD, GAPDH, ALDH2, and ALDH3A1; attenuates ROS-induced pericardial edema in a G6PD-dependent manner in zebrafish, reduces hemolysis of human erythrocytes

G-744 is a highly potent, selective inhibitor of BTK with biochemical Ki of 1.28 nM.

G-749 is an inhibitor of Fms-like tyrosine receptor kinase 3 (FLT3) with IC50 values ranging from 2.1 to 38.1 nM for wild-type and mutant (constitutively active) FLT3s in Ba/F3 cells expressing recombinant receptors.

G907 is a potent, selective small-molecule antagonist of ATP-binding cassette (ABC) transporter MsbA with IC50 of 18 nM.

G9a inhibitor E72 (E-72) is a potent inhibitor of histone H3K9 methyltransferases G9a and G9a-like protein (GLP) with Kd of 136 nM and 164 nM, shows selectivity over the related H3K9 methyltransferase Suv39H2.

Gabapentin (Neurontin) is a pharmaceutical drug, specifically a GABA analog.

Gabapentin (Neurontin) is a pharmaceutical drug, specifically a GABA analog. It was originally developed to treat epilepsy, and currently is also used to relieve neuropathic pain.

Gabexate Mesylate is a Factor X inhibitor.

Gadodiamide is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Target: OthersGadodiamide(Omniscan) is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Gadodiamide is a contrast medium for cranial and spinal magnetic resonance imaging (MRI) and for general MRI of the body after intravenous administration. The product provides contrast enhancement and facilitates visualisation of abnormal structures or lesions in various parts of the body including the central nervous system (CNS). A recent review takes the question of toxicity caused by loss of gadolinium from the complex. "The challenge for nephrologists includes (a) evidence of transmetallation, such as gadolinium deposits in bone, increased urinary zinc excretion, iron-transferrin dissociation or 'spurious hypocalcemia' in exposed people"。

GAK inhibitor 49 is a potent, selective, ATP-competitive inhibitor of cyclin G-associated kinase (GAK, cell IC50=56 nM) with favourable NAK family selectivity (AAK1, STK16, BMP2K).

GAL-021 is a new intravenous BKCa-channel blocker.

Galactose 1-phosphate is an intermediate in the galactose metabolism and nucleotide sugars.

Galactose 1-phosphate Potassium salt is is an intermediate in the galactose metabolism and nucleotide sugars

Galantamine(Narwedin) is a competitive and reversible cholinesterase(AChE) inhibitor.

Galanthamine hydrobromide is a long-acting, centrally active acetylcholinesterase(AChE) inhibitor (IC50 = 410 nM) and allosteric potentiator at neuronal nicotinic ACh receptors.

Galvestine-1 is a small molecule MGDG (monogalactosyldiacylglycerol) synthase inhibitor with IC50 of 10 uM by competing with diacylglycerol binding.

Gambogenic acid (GNA) is a polyprenylated xanthone isolated from gamboge, shows potent antitumor activity and can effectively inhibit the survival and proliferation of cancer cells.

Gambogic Acid activates caspases with EC50 of 0.78-1.64 μM and competitively inhibits Bcl-xl, Bcl-2, Bcl-w, Bcl-B, Bfl-1 and Mcl-1 with IC50 of 1.47 μM, 1.21 μM, 2.02 μM, 0.66 μM, 1.06 μM and 0.79 μM, respectively.

Gamitrinib TPP is a GA mitochondrial matrix inhibitor.

gamma-secretase modulator 3 is a gamma-secretase modulator.

Ganaplacide (KAF156, GNF-156) is a novel antimalarial clinical candidate that shows blood schizonticidal activity with IC50 of 6-17.4 nM against P falciparum drug-sensitive and drug-resistant strains.

Ganciclovir

Ganetespib(STA-9090) is a unique triazolone-containing Hsp90 inhibitor with an IC50 of 4 nM in OSA 8 cells.

Ganirelix is a man-made form of a protein that reduces the amount of certain hormones in the body, including estrogen.

GANT 58 is a novel and potent Gli antagonist that inhibits GLI1-induced transcription (IC50 = 5 uM).

GANT 61(NSC 136476) is a small molecule inhibitor of Gli1 and Gli2.

GAPDS is a small molecule that targets the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH).

Garcinol (Camboginol) is a potent, natural inhibitor of histone acetyltransferases (HATs) p300 (IC50=7 uM) and PCAF (IC50=5 uM) both in vitro and in vivo.

Gardiquimod trifluoroacetate is a specific TLR7 agonist which can also inhibit HIV-1 reverse transcriptase.

Garenoxacin is a quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.

Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains.

GAT-100 (GAT100) is a potent, selective CB1R negative allosteric modulator (NAM) with cAMP EC50 and β-arr EC50 of 174 nM and 2.1 nM, does not exhibit inverse agonism.

GAT-211 (GAT211) is a selective cannabinoid 1 receptor (CB1R) positive allosteric modulator with pKb of 7.26, Arrestin2 EC50 of 775 nM.

GB-110 is a potent, non-peptidic agonist of PAR2 that selectively induces PAR2-mediated intracellular Ca(2+) release in HT29 cells with EC50 of 0.28 uM.

GB1107 (GB-1107, GB 1107) is a potent, selective, orally active inhibitor of Galectin-3 (Gal-3) with Kd of 37 nM (human Galectin-3).

GB-83 is a selective, reversible PAR2 (Protease-activated receptor 2) antagonist with IC50 of 2 uM.

GB-88 is a selective, orally available PAR2 antagonist that inhibits PAR2 activated Ca(2+) release with IC50 of 2 uM.

Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma.

GBR 12935 is a potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat striatal membranes).

GBT-440(Voxelotor) is a novel small molecule hemoglobin modifier which increases hemoglobin oxygen affinity.

GCN2-IN-1 is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with IC50s of <0.3 μM in the enzyme and cell assay.

GDC-0032 is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with IC50 of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.

GDC-0068 is a highly selective pan-Akt inhibitor targeting Akt1, Akt2 and Akt3 with IC50 of 5 nM, 18 nM and 8 nM, respectively.

GDC-0077 is an orally available PI3K inhibitor with potential antineoplastic activity. GDC-0077 is extracted from patent WO 2017001645 A1, formula I.

GDC-0084 （RG7666）, is a phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity.

GDC-0152 is a potent inhibitor of IAPs; binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with K(i) values of 28, 14, 17, and 43 nM, respectively.

GDC-0326 is a potent and selective inhibitor of α-Isoform of Phosphoinositide 3-Kinase (PI3Kalpha inhibitor).

GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM; >700-fold selectivity over PI3Kα and other 266 kinases.

GDC046 is a potent lead analog with good kinase selectivity, physicochemical properties, and pharmacokinetic profile.

GDC0575（ARRY-575，RG7441）is a small molecule inhibitor of cell cycle checkpoint kinase 1 (Chk1), with potential chemosensitization activity.

GDC-0623 is a potent, ATP-uncompetitive inhibitors of MEK1(Ki=0.13 nM, +ATP).

GDC-0853 is orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity.

GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD) for treatment of metastatic hormone receptor-positive/HER2-negative breast cancer..

GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD) for treatment of metastatic hormone receptor-positive/HER2-negative breast cancer..

GDC-0927 Racemate is a degrader of estrogen receptor, potently inhibits ER-α activity, with an IC50 of 0.2 nM, and is used in the research of ER-related diseases.

GDC-0941 2 MeSO3H salt is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM, with modest selectivity against p110β (11-fold) and p110γ (25-fold).

GDC-0941 is a potent inhibitor of PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ with IC50 of 3 nM, 33 nM, 3 nM and 75 nM, respectively.

GDC-0973 is a potent, highly selective inhibitor of mitogen-activated protein kinase kinase, also known as MEK, a serine/threonine kinase that is a component of the RAS/RAF/MEK/ERK pathway.

GDC-0980 (RG7422) is a potent, class I PI3K inhibitor for PI3Kα/β/δ/γ with IC50 of 5 nM/27 nM/7 nM/14 nM, respectively. Also a mTOR inhibitor with Ki of 17 nM, and highly selective versus others PIKK family kinases.

GDC-0994 is a potent, orally available ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1.

GDP366, a dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells.

Gea 3162 is a potent inhibitor of ADP-induced platelet aggregation in platelet rich plasma (PRP). GEA 3162 stimulates cGMP production in platelets, granulocytes, and polymorphonuclear leukocytes.

GeA-69(GeA69) is a potent, selective, allosteric, cell-active PARP14 macrodomain 2 (MD2) inhibitor with Kd of 0.86 uM in ITC assays.

Gefapixant(AF-219,MK-7264) is novel P2X3 receptor antagonist.

Gefitinib (Iressa, ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.

Geldanamycin is a natural existing HSP90 inhibitor with Kd of 1.2 μM, specifically disrupts glucocorticoid receptor (GR)/HSP association.

Gemcabene (PD-72953, PD72953) is a first-in-class lipid-lowering agent and activator of PARP.

Gemcabene (PD-72953, PD72953) is a first-in-class lipid-lowering agent and activator of PARP.

Gemcitabine elaidate is a lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), an antimetabolite deoxynucleoside analogue, with potential antineoplastic activity.

Gemcitabine Hydrochloride (Gemzar) is a DNA synthesis inhibitor with IC50 of 50 nM, 40 nM, 18 nM and 12 nM in PANC1, MIAPaCa2, BxPC3 and Capan2 cells, respectively,showed potent activity against COVID-19(SARS-COV-2) with EC50 MERS-COV(1.216), SARS-COV(4.9

Gemcitabine monophosphate disodium salt, also called GemMP, is a monophosphate derivative of Gemcitabine.

Gemcitabine(Gemzar) belongs to the group of medicines called antimetabolites.

Gemfibrozil (Lopid)

Gemifloxacin mesylate (trade name Factive, Oscient Pharmaceuticals) is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia.

Gemilukast is an orally active and potent dual cysteinyl leukotriene 1 and 2 receptors (CysLT1 and CysLT2) antagonist, with IC50s of 1.7, 25 nM for human CysLT1 and CysLT2, respectively.

Genipin

Geniposide

Geniposidic acid

Genistein is a highly specific inhibitor of protein tyrosine kinase (PTK).

Genistin is an isoflavone glycoside found in soy-based products. Can be used as a negative control for the PTK inhibitor Genistein

Gentamycin sulfate (Gentacycol)

Genz-123346 free base is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1; IC50 for GM1 inhibition is 14 nM.

Genz-644282 is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity(IC50=1.2 nM).

Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor.

Geraniin is a TNF-α releasing inhibitor with numerous activities including anticancer, anti-inflammatory, and anti-hyperglycemic activities, with an IC50 of 43 μM.

Geranylgeranylacetone can induce expression of HSP70, HSPB8, and HSPB1. Induction of HSP70 expression is protective against the development of various diseases, such as hypoxic/ischemic brain injury, inflammatory bowel disease and spinal and bulbar muscul

Gerfelin is an osteoclastogenesis inhibitor (IC50=61 uM) through the competitive inhibition of glyoxalase I (GLO1) with Ki of 0.15 uM.

Gestodene(SHB 331;WL 70) is a progestogen hormonal contraceptive.

Gestrinone (R2323) is a synthetic steroid hormone used to treat endometriosis. It inhibits leiomyoma cells with an IC50 of 43.67 μM.

GF109203X is a potent PKC inhibitor with IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ, respectively, showing more than 3000-fold selectivity for PKC as compared to EGFR, PDGFR and insulin receptor.

GGTI 2417 is the methyl ester prodrug of GGTI-2418, a highly potent, competitive, and selective inhibitor of GGTase I.

GGTI 2418 (PTX 100) is a highly potent, competitive, and selective peptidomimetic inhibitor of geranylgeranyltransferase I (GGTI) with IC50 of 9.5 nM, displays 5,600-fold selectivity over FTase.

GGTI 2418 sodium (PTX 100) is a highly potent, competitive, and selective peptidomimetic inhibitor of geranylgeranyltransferase I (GGTI) with IC50 of 9.5 nM, displays 5,600-fold selectivity over FTase.